POLDIP2 Antibody [N1K14]

N° de catalogue F3409

Imprimer

Description biologique

Spécificité POLDIP2 Antibody [N1K14] détecte les niveaux endogènes de la protéine POLDIP2 totale.
Contexte POLDIP2 (protéine 2 interagissant avec la polymérase δ) est une protéine multifonctionnelle exprimée le plus abondamment dans le cœur et les muscles squelettiques, caractérisée par une structure globulaire compacte à deux domaines riche en brins β avec une région non structurée dynamique N-terminale attachée par un lieur étendu à un cœur rigide comprenant un domaine de type YccV et un domaine DUF525 juxtaposé qui forment ensemble un canal central. Ses boucles inter-brins confèrent une flexibilité conformationnelle, facilitant les interactions avec diverses protéines partenaires. POLDIP2 fonctionne comme un cofacteur essentiel pour l'ADN polymérase δ, améliorant la stabilité de la fourche de réplication par interaction avec PCNA et stimulant la processivité de PrimPol et le contournement sans erreur des lésions de l'ADN oxydatives en se liant au domaine catalytique. Il soutient également l'intégrité génomique en coordonnant la réparation par excision de base et la recombinaison homologue en conjonction avec RAD51. POLDIP2 régule dynamiquement la production d'espèces réactives de l'oxygène médiée par Nox4/p22^phox, qui est essentielle pour le renouvellement des adhésions focales et le remodelage du cytosquelette pendant la migration des cellules musculaires lisses vasculaires. POLDIP2 contrôle la lipoylation des complexes PDH et αKGDH en inhibant la dégradation d'ACSM1 médiée par la protéase Clp dans des conditions hypoxiques régulées par HIF-1α, préservant ainsi le métabolisme oxydatif. La perte de POLDIP2 entraîne un dysfonctionnement mitochondrial et une reprogrammation métabolique rétrograde, tandis que sa surexpression contribue à l'inflammation de la rétinopathie diabétique par la dégradation de Pink1 et l'inhibition de la mitophagie. La dérégulation de POLDIP2 a également été impliquée dans la promotion de la prolifération des cellules cancéreuses, des maladies cardiovasculaires par l'hyperactivation endothéliale de Nox4 et la néovascularisation pathologique via des effets sur le cytosquelette.

Informations dutilisation

Application WB, IP, IF Dilution
WB IP FCM
1:1000 - 1:10000 1:40 1:350
Réactivité Human
Source Rabbit Monoclonal Antibody MW 42 kDa
Tampon de stockage PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Stockage
(À partir de la date de réception)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/Nuclear Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.
IF
Experimental Protocol:
 
Sample Preparation
1. Adherent Cells: Place a clean, sterile coverslip in a culture dish. Once the cells grow to near confluence as a monolayer, remove the coverslip for further use.
2. Suspension Cells: Seed the cells onto a clean, sterile slide coated with poly-L-lysine.
3. Frozen Sections: Allow the slide to thaw at room temperature. Wash it with pure water or PBS for 2 times, 3 minutes each time.
4. Paraffin Sections: Deparaffinization and rehydration. Wash the slide with pure water or PBS for 3 times, 3 minutes each time. Then perform antigen retrieval.
 
Fixation
1. Fix the cell coverslips/spots or tissue sections at room temperature using a fixative such as 4% paraformaldehyde (4% PFA) for 10-15 minutes.
2. Wash the sample with PBS for 3 times, 3 minutes each time.
 
Permeabilization
1.Add a detergent such as 0.1–0.3% Triton X-100 to the sample and incubate at room temperature for 10–20 minutes.
(Note: This step is only required for intracellular antigens. For antigens expressed on the cell membrane, this step is unnecessary.)
Wash the sample with PBS for 3 times, 3 minutes each time.
 
Blocking
Add blocking solution and incubate at room temperature for at least 1 hour. (Common blocking solutions include: serum from the same source as the secondary antibody, BSA, or goat serum.)
Note: Ensure the sample remains moist during and after the blocking step to prevent drying, which can lead to high background.
 
Immunofluorescence Staining (Day 1)
1. Remove the blocking solution and add the diluted primary antibody.
2. Incubate the sample in a humidified chamber at 4°C overnight.
 
Immunofluorescence Staining (Day 2)
1. Remove the primary antibody and wash with PBST for 3 times, 5 minutes each time.
2. Add the diluted fluorescent secondary antibody and incubate in the dark at 4°C for 1–2 hours.
3. Remove the secondary antibody and wash with PBST for 3 times, 5 minutes each time.
4. Add diluted DAPI and incubate at room temperature in the dark for 5–10 minutes.
5. Wash with PBST for 3 times, 5 minutes each time.
 
Mounting
1. Mount the sample with an anti-fade mounting medium.
2. Allow the slide to dry at room temperature overnight in the dark.
3. Store the slide in a slide storage box at 4°C, protected from light.
 

Références

  • https://pubmed.ncbi.nlm.nih.gov/29434038/
  • https://pubmed.ncbi.nlm.nih.gov/33884680/

Données dapplication

WB

Validé par Selleck

  • F3409-wb
    Lane 1: Hela, Lane 2: HepG2